Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 1
Submit an article Journal homepage
318
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma

Rohit ThummalapalliDepartment of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA;
,
Laura A. SenaDepartment of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA;
,
John C. ProbascoDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
&
Douglas E. GladstoneDepartment of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; Correspondence[email protected]
Pages 228-230 | Received 02 Jul 2019, Accepted 12 Aug 2019, Published online: 10 Sep 2019

References

  • Schoch LK, Cooke KR, Wagner-Johnston ND, et al. Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide. Blood Adv. 2018;2:2226–2261.
  • Williams TJ, Benavides DR, Patrice KA, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol. 2016;73:928–933.
  • Burke M, Hardesty M, Downs W. A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer. Gyn Onc Reports. 2018;24:51–53.
  • Boyd K, Kalladka D, Overell J, et al. Ipilimumab induced encephalitis: a case report. Immunome Res. 2015;11:092.
  • Yeshokumar AK, Gordon-Lipkin E, Arenivas A, et al. Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunology. 2017;312:8–14.
  • Rathore GS, Leung KS, Muscal E. Autoimmune encephalitis following bone marrow transplantation. Pediatr Neurol. 2015;53:253–256.
  • Kamble RT, Chang CC, Sanchez S, et al. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant. 2007;39:49–52.
  • De La Hoz A, Foolad F, Gallegos C, et al. Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin’s disease. Bone Marrow Transplant. 2019;54:749–751.
  • Shi J, Hou S, Fang Q, et al. PD-1 controls follicular t helper cell positioning and function. Immunity. 2018;49:264–274.
  • Katz DH, Paul WE, Goidl EA, et al. Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med. 1971;133:169–186.
  • Gladstone DE, Golightly MG, Brannagan TH. High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients. J Neuroimmunology. 2007;190:121–126.
  • Saha A, Aoyama K, Taylor PA, et al. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. Blood. 2013;122:3062–3073.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.